Financials
Financial year 2025
DR DEFOURNY biologie clinique from Ham-sur-Heure-Nalinnes, company number BE0721772446, closed financial year 2025 with a result of € 107,877 after tax. For that financial year DR DEFOURNY biologie clinique recorded a gross margin of € 149,635 and equity of € 20,460. Compared with financial year 2024, the result moved from € 105,945 to € 107,877. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 20,460
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 107,877
▲ 2% vs 2024
Profit after tax over the fiscal year.
€ 83,872
▲ € 63,919 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 107,877 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 19,733
▲ 156% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,065
▼ 3% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 862
▼ 60% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 153,063 | € 205,511 | € 141,309 | € 149,635 | ▲ 6% |
| Profit after taxes | € 116,684 | € 154,256 | € 105,945 | € 107,877 | ▲ 2% |
| Equity | € 20,460 | € 20,460 | € 20,460 | € 20,460 | |
| Total debts | € 124,959 | € 169,333 | € 20,307 | € 95,228 | ▲ € 74,921 |
| Cash | € 83,702 | € 124,993 | € 19,952 | € 83,872 | ▲ € 63,919 |
| Retained profit | € 1,860 | € 1,860 | € 1,860 | € 1,860 | |
| Dividend | € 322,832 | € 154,256 | € 105,945 | € 107,877 | ▲ 2% |
| Balance sheet total | € 145,419 | € 189,793 | € 40,767 | € 115,688 | ▲ 184% |
Key figures of DR DEFOURNY biologie clinique, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR DEFOURNY biologie clinique?
What happened at DR DEFOURNY biologie clinique in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 107,877 (▲ 2% vs 2024). Source: NBB ↗
- New establishment in Ham-sur-Heure-Nalinnes. KBO
- Start of the company according to the CBE. KBO
In short
From € 116,684 profit in 2022 to € 107,877 profit in 2025.
Paid € 140,082 in corporate taxes since 2022.
Best year ever: 2023, with € 154,256 profit.
Paid out € 690,910 in dividends to the owners in total.
Management
Behind DR DEFOURNY biologie clinique is Lydwine Defourny.
Directors
According to the 2025 annual accounts
Lydwine Defourny
Director
Establishments
Establishment units
Physical locations of this company
Rue du Vert Logis(JAM) 22
6120 Ham-sur-Heure-Nalinnes
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0721.772.446
- VAT number
- BE 0721.772.446
- Registered office
- Rue du Vert Logis(JAM) 22, 6120 Ham-sur-Heure-Nalinnes
- Names & denominations
- DR DEFOURNY biologie clinique · DDBC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 March 2019
- Peppol
- Active · Active since 12 Dec 2025